Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007

Company Provides Update on Oncology Pipeline Progress

SAN DIEGO, Nov. 13 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced financial results for the three and nine months ended September 30, 2007. For the three months ended September 30, 2007, the Company posted revenues of $7.6 million and a net loss of $4.8 million. For the nine months ended September 30, 2007, revenues were $27.1 million and the net loss was $9.9 million. Cash, cash equivalents and short-term investments totaled $21.4 million at September 30, 2007 compared to $33.9 million at December 31, 2006.

Pipeline Update

* The IND submission for SGX523, the Company's lead MET inhibitor, is

expected to be made prior to year end, with Phase 1 clinical trials

anticipated to begin in early 2008. The Company is also moving

forward a number of other MET inhibitors with differing profiles to

SGX523 to further broaden the scope of the program.

* SGX393, a BCR-ABL inhibitor the Company is developing for the

relapsed/refractory Chronic Myelogenous Leukemia (CML) patient

population, is in formal toxicology studies and an IND submission is

targeted for the first half of 2008. Initial clinical studies are

planned to focus on patients with the most clinically challenging

CML mutation, known as the T315I mutant.

* Other BCR-ABL inhibitors, with potential to target the front-line

patient population, are undergoing preclinical studies in

collaboration with Novartis.

"We are excited about the progress of our pipeline candidates this quarter, particularly in our M

SOURCE SGX Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
(Date:8/30/2014)... India (PRWEB) August 30, 2014, ... reputation management industry, has announced to offer guarantee of ... decided to offer this guarantee because of its tremendous ... than 200 clients from all over the world and ... extremely good job. , On being asked about ...
(Date:8/30/2014)... (PRWEB) August 30, 2014, a company ... as other healthy lifestyle resources, is proud to announce it ... resources for at home fitness solutions by ABC’s Good Morning ... featured story on ABC’s Good Morning America, “Live Streaming Fitness ... can streamline your day by streamlining your workout…to boot camp ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Jake W., 18, ... while in the Back2Basics Outdoor Adventures transition program ... finish high school so I can actually start on a ... and math, and I'm done.” , He has six months ... Back2Basics program. Most clients choose to continue on to the ...
(Date:8/30/2014)... McLeod's Sunset Park Auto Service , ... with strong ties to the community celebrates sixty years in ... they have been chosen by The Tampa Tribune’s ... , Tim McLeod’s father, Norris (most know him as ... Although his son, Tim runs the day to day, taking ...
(Date:8/30/2014)... Final Cut Pro X plugin ... plugin from Pixel Film Studios. , “The TrasGhost plugin ... to tell their scary story in a suspenseful way.” ... will make their audience scream with this bone chilling ... users can awaken evil spirits with over 40 action ...
Breaking Medicine News(10 mins):Health Announces Guaranteed Complaints Removal Services 2Health is New Trend In Fitness 2Health News:McLeod's Sunset Park Auto Service Celebrates 60 Years Honored with Best of South Tampa 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 3
... OH (May 29, 2012) A great deal has been ... Women,s Health Initiative (WHI) were published on July 9, 2002. ... women using hormone therapy (HT). The 27,000 women were prescribed ... 7 years, respectively. Researchers expected to find that hormones ...
... the death toll is relatively low for people who ... severe, life-long consequences for brain function. TBI can impair ... lead to dramatic personality changes. And long-term medical treatment ... commissioned by the United States Air Force, Prof. Chaim ...
... Seoul, South Korea, May 29, 2012 -- The discovery ... an Israeli-South Korean scientific team to conduct a genetic analysis ... virus (HBV) genotype C2 sequence common in Southeast Asia. ... used as a model to study the evolution of chronic ...
... May 29, 2012 -- The American College of Physicians (ACP), ... Million Hearts, a public-private sector initiative that aims to prevent ... Hearts has two primary goals: Empowering Americans ... reducing sodium and trans fat consumption. This can reduce the ...
... There is a correlation between high levels of the environmental ... abdomen. This is shown in a new study published today ... already known to increase the risk of diabetes and high ... (visceral fat) is considerably more dangerous that fat near the ...
... HealthDay Reporter , MONDAY, May 28 (HealthDay News) -- Women ... might be increasing their risk for breast cancer, Danish researchers ... highest among women who describe themselves as "morning" people rather ... 20 percent of women in modern societies have night shift ...
Cached Medicine News:Health News:Diabetes drug could be a promising therapy for traumatic brain injury 2Health News:Diabetes drug could be a promising therapy for traumatic brain injury 3Health News:16th-century Korean mummy provides clue to hepatitis B virus genetic code 2Health News:ACP joins Million Hearts to help save lives from preventable heart attacks and strokes 2Health News:PCB can increase risk of abdominal fat 2Health News:Night Shift Might Boost Women's Breast Cancer Risk: Study 2Health News:Night Shift Might Boost Women's Breast Cancer Risk: Study 3Health News:Night Shift Might Boost Women's Breast Cancer Risk: Study 4
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely eradicated ... generation ago are returning. Measles was declared eliminated in ... 2014 as of August 15—the highest incidence in 20 ... health department declared whooping cough a problem of ... getting sick and dying from these preventable diseases—in part ...
(Date:8/29/2014)... , Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood instrumentation and consumables to the medical, research ... , Chairman and Chief Executive Officer, will present at ... Conference 2014 on Tuesday, September 9, 2014 at 12:30 ... Omni Berkshire Place Hotel in New York ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure....
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... The AirHeel™ is specifically designed to treat Achilles ... located under the foot arch and in back ... with every step to help reduce swelling and ... neoprene fabric and is simple to apply ...
... An excellent preventative/thera-peutic device for ... Helps dampen vibration and shock ... motion. Provides relief from painful ... pad is easily detachable from the ...
Medicine Products: